🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death
🏥 Hospitalized
🚑 Emergency Room
♿ Disability
⚠️ Life Threatening

How to Search

💡 Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

💡 Frequently Asked Questions (FAQ)

What is this site?

🏥 VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • ✅ Early warning system for potential safety signals
  • ✅ Open and transparent - publicly accessible
  • ✅ Accepts all reports regardless of likelihood of causation
  • ✅ Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
🔄 Reset 📥 Export CSV
ID Age Sex State Date ▼ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative 💀 🏥 🚑 ♿ ⚠️
2848331 MO 07/03/2025 VARCEL
 MERCK & CO. INC.
 Y015108
No adverse event, Product storage error No adverse event, Product storage error
No symptoms reported. No additional AE; This case pertains to one patient who received improperly st... No symptoms reported. No additional AE; This case pertains to one patient who received improperly stored VARIVAX on 06/18/2025.; This spontaneous report has been received from a nurse, regarding to patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On 18-JUN-2025, the patient was vaccinated with improperly storage of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) at a dose of 0.5 milliliter (ml) (lot #Y015108, expiration date: 06-SEP-2026) plus sterile diluent as prophylaxis (dose, route of administration, and anatomical site of injection were not reported). The administered doses were stored at a temperature of 6.3 degrees Fahrenheit (F) during a time frame of 16 minutes (product storage error). There was no previous temperature excursion. No additional side effects were reported in the patients. More
2848332 M 07/03/2025 RVX
 UNKNOWN MANUFACTURER
 UNK
Death Death
died 2 days after the shot; This serious case was reported by a consumer via interactive digital me... died 2 days after the shot; This serious case was reported by a consumer via interactive digital media and described the occurrence of unknown cause of death in a male patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, 2 days after receiving RSV vaccine, the patient experienced unknown cause of death (Verbatim: died 2 days after the shot) (serious criteria death and GSK medically significant). The reported cause of death was unknown. It was unknown if the reporter considered the unknown cause of death to be related to RSV vaccine. The company considered the unknown cause of death to be unrelated to RSV vaccine. Additional Information: GSK Receipt Date: 30-JUN-2025 This case was reported by a consumer via interactive digital media. The reporter husband died 2 days after the shot.; Sender's Comments: Death is an unlisted event which is considered unrelated to GSK RSV vaccine.; Reported Cause(s) of Death: Unknown cause of death More
✓
2848333 F AZ 07/03/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 UNK
UNK
Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure
Shingles developed in the same area: on the Right cheek, near the eye.; Suspected Vaccination failur... Shingles developed in the same area: on the Right cheek, near the eye.; Suspected Vaccination failure; Shingles developed in the same area: on the Right cheek, near the eye.; This serious case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 90-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included blood pressure high. On 20-JAN-2021, the patient received the 2nd dose of Shingrix. On 20-NOV-2020, the patient received the 1st dose of Shingrix. On 03-MAR-2025, 1503 days after receiving Shingrix and 1564 days after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Suspected Vaccination failure) (serious criteria GSK medically significant) and facial herpes zoster (Verbatim: Shingles developed in the same area: on the Right cheek, near the eye.). On 15-JUN-2025, the patient experienced facial herpes zoster (Verbatim: Shingles developed in the same area: on the Right cheek, near the eye.). The patient was treated with valaciclovir (Valacyclovir). The outcome of the vaccination failure was not reported and the outcome of the facial herpes zoster and facial herpes zoster were unknown. It was unknown if the reporter considered the vaccination failure, facial herpes zoster and facial herpes zoster to be related to Shingrix and Shingrix. The company considered the vaccination failure to be unrelated to Shingrix and Shingrix. It was unknown if the company considered the facial herpes zoster and facial herpes zoster to be related to Shingrix and Shingrix. Additional Information: GSK Receipt Date: 23-JUN-2025 The patient did not provide her date of birth but states she was 90 years old. The patient could not locate the contact information for her healthcare professional. The reporter was the patient. The patient received the first dose of Shingrix on 20 November 2020, and the second dose 20 January 2021. On 3 March 2025 the patient developed shingles.On 15 June 2025, the patient developed shingles again. Both times, the shingles developed in the same area on the Right cheek, near the eye. The patient was treated both times with valacyclovir.For the first episode of shingles the patient was given valacyclovir l gram twice daily for 7 days; the second episode the patient was given valacyclovir l gram three times daily for 7 days. The recommended dosing for valacyclovir for herpes zoster treatment was 1 gram 3 times daily for 7 days. However caution should be exercised when administering valtrex to geriatric patients, and dosage reduction was recommended for those with impaired renal function.Elderly patients were more likely to have reduced renal function and require dose reduction.The patient was 90 years of age. Captured for under dose and over dose for valacyclovir were captured to be prudent. The patient renal function was not provided at the time of this report. Adverse event of potential under dose (1 gram twice daily for 7 days) was captured as the recommended dosing was 1 gram 3 times daily; but it was important to note that the patient was 90 years of age and the decreased dose may be due to patient renal function. Potential over dose (1 gram three times daily for 7 days) were captured because the patient was 90 years of age, and maybe too high for this patient. This case was considered as suspected vaccination failure as details regarding laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingrix (dose 1) and Shingrix (dose 2). More
2848334 66 F PA 07/03/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 UNK
UNK
Chills, Erythema, Eye pain, Headache, Influenza; Pain in extremity, Pain in jaw,... Chills, Erythema, Eye pain, Headache, Influenza; Pain in extremity, Pain in jaw, Pyrexia More
arm pain; Fever; Chills/Shivering; Eye pain; Jaw pain; Flu symptoms; redness in her face; Headache; ... arm pain; Fever; Chills/Shivering; Eye pain; Jaw pain; Flu symptoms; redness in her face; Headache; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included parathyroid tumor (Parathyroid tumor). On 20-JUN-2025, the patient received the 1st dose of Shingrix. In JUN-2025, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: arm pain), fever (Verbatim: Fever), chills (Verbatim: Chills/Shivering), eye pain (Verbatim: Eye pain), jaw pain (Verbatim: Jaw pain), flu symptoms (Verbatim: Flu symptoms), red face (Verbatim: redness in her face) and headache (Verbatim: Headache). The outcome of the pain in arm, fever, chills, eye pain, jaw pain, flu symptoms, red face and headache were unknown. It was unknown if the reporter considered the pain in arm, fever, chills, eye pain, jaw pain, flu symptoms, red face and headache to be related to Shingrix. It was unknown if the company considered the pain in arm, fever, chills, eye pain, jaw pain, flu symptoms, red face and headache to be related to Shingrix. Additional Information: GSK Receipt Date: 27-JUN-2025 The reporter was the patient who received her first dose of Shingrix on June 20th. The reporter reported that arm pain, redness in her face, flu symptoms, fever, chills, headache, eye pain, shivering, and jaw pain. The reporter was going to get a nuclear CT on Tuesday to check for a parathyroid tumor. More
2848335 07/03/2025 RVX
RVX
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
 UNK
UNK
Cough, Malaise, Respiratory syncytial virus infection, Respiratory syncytial vir... Cough, Malaise, Respiratory syncytial virus infection, Respiratory syncytial virus test positive, Vaccination failure; X-ray More
Suspected vaccination failure; RSV infection/ RSV vaccine last fall and I have it now/cough; been ve... Suspected vaccination failure; RSV infection/ RSV vaccine last fall and I have it now/cough; been very sick for about 10 days; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), respiratory syncytial virus infection (Verbatim: RSV infection/ RSV vaccine last fall and I have it now/cough) and sickness (Verbatim: been very sick for about 10 days). The patient was treated with antibiotics. The outcome of the vaccination failure was not reported and the outcome of the respiratory syncytial virus infection was not resolved and the outcome of the sickness was resolved (duration 10 days). It was unknown if the reporter considered the vaccination failure, respiratory syncytial virus infection and sickness to be related to RSV vaccine. The company considered the vaccination failure to be unrelated to RSV vaccine. It was unknown if the company considered the respiratory syncytial virus infection and sickness to be related to RSV vaccine. Additional Information: GSK Receipt Date:18-JUN-2025 and 19-JUN-2025 This case was reported by a patient via interactive digital media. The patient had been very sick for 10 days and now (during the reporting days) the urgent care had sent the patient home with an antibiotic and cough pills, but the patient continued to get worse. They did not even take an x-ray of the patient's chest and was going to the emergency room (ER) on the day of reporting and believed it was respiratory syncytial virus infection (RSV) even though the patient had the RSV shot last fall in 2024 and have it now and had been very sick for about 10 days. So, the patient hates to say it just like the covid vaccine not every vaccine was perfect to do have RSV vaccine. The hospital did an x-ray and test for RSV covid flu and he/she was positive for RSV and felt very bad. The cough was so bad, and his/her oxygen level stayed at about a 90 to 94. This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of respiratory syncytial virus infection were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, time to onset and laboratory confirmation of disease) is considered unrelated to GSK RSV vaccine. More
2848336 M 07/03/2025 VARZOS
VARZOS
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
 UNK
UNK
Herpes zoster, Ophthalmic herpes zoster, Vaccination failure; Herpes zoster, Oph... Herpes zoster, Ophthalmic herpes zoster, Vaccination failure; Herpes zoster, Ophthalmic herpes zoster, Vaccination failure More
suspected vaccination failure; shingles into the eye; shingles on the right side of his face; This s... suspected vaccination failure; shingles into the eye; shingles on the right side of his face; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included leukemia (patient was immune compromised because of leukemia four years ago). On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: suspected vaccination failure) (serious criteria GSK medically significant), ophthalmic herpes zoster (Verbatim: shingles into the eye) (serious criteria GSK medically significant) and facial herpes zoster (Verbatim: shingles on the right side of his face). The outcome of the vaccination failure was not reported and the outcome of the ophthalmic herpes zoster and facial herpes zoster were not resolved. It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster and facial herpes zoster to be related to Shingles vaccine and Shingles vaccine. The company considered the vaccination failure and ophthalmic herpes zoster to be unrelated to Shingles vaccine and Shingles vaccine. It was unknown if the company considered the facial herpes zoster to be related to Shingles vaccine and Shingles vaccine. Additional Information: GSK Receipt Date: 27-JUN-2025 Patient was immune compromised because of leukemia four years ago. They wiped out his immune system to get the stem cell transplant and now he had all his childhood vaccinations, and the shingle shot was a last one. Patient had first shot 6 months ago and second one 6 weeks ago and now has shingles on the right side of his face and into the eye. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, time to onset, and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingles vaccine (dose 1 and 2) Ophthalmic herpes zoster is an unlisted event which is considered unrelated to GSK vaccine Shingles vaccine (dose 1 and 2) More
2848337 M 07/03/2025 RVX
 UNKNOWN MANUFACTURER
 UNK
Cough Cough
bad cough ever since; This non-serious case was reported by a consumer via interactive digital media... bad cough ever since; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of cough in a 81-year-old male patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced cough (Verbatim: bad cough ever since). The outcome of the cough was not resolved. It was unknown if the reporter considered the cough to be related to RSV vaccine. It was unknown if the company considered the cough to be related to RSV vaccine. Additional Information: GSK Receipt Date: 30-JUN-2025 This case was reported by a consumer via interactive digital media. Reporter's 81-year-old husband had received this shot the previous year and had developed a bad cough ever since. She had decided not to receive this vaccination. More
2848338 07/03/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Herpes zoster, Vaccination failure Herpes zoster, Vaccination failure
Suspected vaccination failure; got the shot and came down with shingles; This serious case was repor... Suspected vaccination failure; got the shot and came down with shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: got the shot and came down with shingles). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 30-JUN-2025 This case was reported by a patient via interactive digital media. The reporter reported that two friends from work got the shot and came down with shingles. That frightened to reporter away from any of that. So far reporter was good, no shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingles vaccine. More
2848339 M 07/03/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Death Death
died in his sleep; This serious case was reported by a consumer via interactive digital media and de... died in his sleep; This serious case was reported by a consumer via interactive digital media and described the occurrence of died in sleep in a 50-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. In MAY-2025, the patient received Shingles vaccine. In MAY-2025, less than a day after receiving Shingles vaccine, the patient experienced died in sleep (Verbatim: died in his sleep) (serious criteria death and GSK medically significant). The patient died in MAY-2025. The reported cause of death was died in sleep. It was unknown if the reporter considered the died in sleep to be related to Shingles vaccine. The company considered the died in sleep to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 25-JUN-2025 This case was reported by the patient's friend via interactive digital media. The reporter had a 50-year-old friend who took the Shingles vaccine about a month ago. He had died in his sleep that night. He had no previous health issues. Vaccines had started to appear more and more like the real threat to our health. It was sad to see big pharma continuing to use scare tactics to get people lined up for their products.; Sender's Comments: Death is an unlisted event which is considered unrelated to GSK''s Shingles vaccine.; Reported Cause(s) of Death: died in sleep More
✓
2848340 F AK 07/03/2025 DTAPIPV
 GLAXOSMITHKLINE BIOLOGICALS
 5H95B
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
Patient received a dose of Kinrix out of the recommended age (patient is less than 4 years old); Thi... Patient received a dose of Kinrix out of the recommended age (patient is less than 4 years old); This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old female patient who received DTPa-IPV (Kinrix) (batch number 5H95B, expiry date 16-FEB-2026) for prophylaxis. On 20-SEP-2024, the patient received Kinrix. On 20-SEP-2024, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Patient received a dose of Kinrix out of the recommended age (patient is less than 4 years old)). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-JUN-2025 The nurse reported that they administered a dose of Kinrix to 6 different patients under the age of 4 years old. One year old female patient received Kinrix which led to inappropriate age at vaccine administration. The reporter wanted to know if they need to continue with the same schedule as recommended in the package insert. This is 1 of 6 linked cases, reported by the same reporter.; Sender's Comments: GSK-US2025076584:Same reporter/Diffrent patient US-GSK-US2025076595:Same reporter/Diffrent patient US-GSK-US2025076587:Same reporter/Diffrent patient US-GSK-US2025076588:Same reporter/Diffrent patient US-GSK-US2025076583:Same reporter/Diffrent patient More
2848341 F VA 07/03/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 UNK
Incomplete course of vaccination Incomplete course of vaccination
Late Dose; This non-serious case was reported by a other health professional via call center represe... Late Dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a adult female patient who did not receive Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (1st dose received on 06-MAR-2024). On an unknown date, the patient did not receive the 2nd dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incomplete course of vaccination (Verbatim: Late Dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-JUN-2025 The reporter have a patient came for her second dose but were just informed that the patient was in her first trimester or 8 weeks pregnant and just wanted to get clarification that it was ok to give that vaccine. The vaccine was not administered during pregnancy. Till the time of reporting the patient had not received the second dose of Bexsero, which led to incomplete course of vaccination. More
2848342 M OR 07/03/2025 HEPA
 GLAXOSMITHKLINE BIOLOGICALS
 42DM9
Product storage error Product storage error
Havrix plus administration after temperature excursion; This non-serious case was reported by a phar... Havrix plus administration after temperature excursion; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a 18-month-old male patient who received HAV (Havrix) (batch number 42DM9, expiry date 22-JAN-2027) for prophylaxis. On 20-JUN-2025, the patient received Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced incorrect storage of drug (Verbatim: Havrix plus administration after temperature excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 24-JUN-2025 Pharmacist called to verify if doses of vaccines that had been exposed to low temperatures should be repeated. Havrix temperature was 26.5 degree fahrenheit which led to incorrect storage of drug. This case has been linked to US2025079382 reported by the same reporter different patient.; Sender's Comments: US-GSK-US2025079382:Same reporter different patient More
2848343 M OR 07/03/2025 MNQ
 NOVARTIS VACCINES AND DIAGNOSTICS
 9X7CD
Product storage error Product storage error
Menveo administration after temperature excursion; This non-serious case was reported by a pharmacis... Menveo administration after temperature excursion; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number 9X7CD, expiry date 31-JAN-2026) for prophylaxis. On 19-JUN-2025, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced incorrect storage of drug (Verbatim: Menveo administration after temperature excursion). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK receipt date: 24-JUN-2025 Th pharmacist called to verify if doses of vaccines that have been exposed to low temperatures should be repeated. The patient was given the vaccine after temperature excursion which led to incorrect storage of drug. This was 1 of the 6 linked cases reported by the same reporter.; Sender's Comments: US-GSK-US2025079376:Same reporter different patient US-GSK-US2025079384:Same reporter different patient US-GSK-US2025079381:Same reporter different patient US-GSK-US2025079375:Same reporter different patient US-GSK-US2025079387:Same reporter different patient More
2848344 F OR 07/03/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 EB499
Product storage error Product storage error
Boostrix + Administration after temperature excursion; This non-serious case was reported by a pharm... Boostrix + Administration after temperature excursion; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a 11-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number EB499, expiry date 26-AUG-2027) for prophylaxis. On 19-JUN-2025 08:30, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced incorrect storage of drug (Verbatim: Boostrix + Administration after temperature excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-JUN-2025 The pharmacist had called to verify whether doses of vaccines that had been exposed to low temperatures needed to be repeated. Patient received Boostrix after temperature excursion, which led to Incorrect storage of drug. More
2848345 77 F OH 07/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Incomplete course of vaccination Incomplete course of vaccination
totally forgot to get her Second dose; This non-serious case was reported by a pharmacist via call c... totally forgot to get her Second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (Received 1st dose of Shingrix vaccine on 04-SEP-2023 (batch number 274YD and expiry date 15-SEP-2025)). The patient did not receive the 2nd dose of Shingrix. The patient had incomplete course of vaccination (Verbatim: totally forgot to get her Second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 24-JUN-2025 Pharmacist reported that there is supposed to be a series of two within 2 to 6 months from the first dose about the Shingrix vaccine. This patient they had, she received one on 2023 but she totally forgot to get her Second one which led to incomplete course of vaccination. The reporter wanted to know if she had to start over and get two or was it okay to give her just one. More
2848346 3 M MI 07/03/2025 DTAPIPV
 GLAXOSMITHKLINE BIOLOGICALS
 5H95B
Product administered to patient of inappropriate age, Wrong product administered Product administered to patient of inappropriate age, Wrong product administered
Wrong vaccine administration; This non-serious case was reported by a other health professional via ... Wrong vaccine administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 3-year-old male patient who received DTPa-IPV (Kinrix) (batch number 5H95B, expiry date 16-FEB-2026) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. On 21-APR-2025, the patient received the 3rd dose of Kinrix. On an unknown date, the patient did not receive Pediarix. On 21-APR-2025, an unknown time after receiving Kinrix and not applicable after receiving Pediarix, the patient experienced wrong vaccine administered (Verbatim: Wrong vaccine administration). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 25-JUN-2025 On 25th June 2025, a registered nurse called to report the administration of a Kinrix shot to a 3 year and 9-month-old male patient instead of Pediarix in the DTaP immunization series which led to wrong vaccine administration. The vaccine was administered on 21st April 2025 and was for the third dose. She called to know how to proceed, do they need to revaccinate and make a Safety report? More
2848347 07/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Incomplete course of vaccination Incomplete course of vaccination
received the first Shingrix dose more than 1 year ago; This non-serious case was reported by a pharm... received the first Shingrix dose more than 1 year ago; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received the first Shingrix dose more than 1 year ago). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after not receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: received the first Shingrix dose more than 1 year ago). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 26-JUN-2025 The reporter mentioned that a patient received the first Shingrix dose more than 1 year ago. They were asking if the patient should re start the series. No further details provided. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. More
2848348 M TN 07/03/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 Y3Z9P
Wrong technique in product usage process Wrong technique in product usage process
it was not shaken vigorously before administration; This non-serious case was reported by a pharmaci... it was not shaken vigorously before administration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong technique in product usage process in a 92-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number Y3Z9P, expiry date 27-AUG-2027) for prophylaxis. On 26-JUN-2025, the patient received Boostrix. On 26-JUN-2025, an unknown time after receiving Boostrix, the patient experienced wrong technique in product usage process (Verbatim: it was not shaken vigorously before administration). The outcome of the wrong technique in product usage process was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 26-JUN-2025 The pharmacist reported that a patient that was administered with a Boostrix vaccine and it was not shaken vigorously before administration, which led to wrong technique in product usage process The reporter asked was there any advice on this and if they need to revaccinate or so. The Vaccine Administration Facility is the same as Primary Reporter More
2848349 M MS 07/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 X5T42215ZK
Injection site discomfort, Injection site pain Injection site discomfort, Injection site pain
having a b urning sensation and discomfort at the injection site.; having a b urning sensation and d... having a b urning sensation and discomfort at the injection site.; having a b urning sensation and discomfort at the injection site.; This non-serious case was reported by a physician via call center representative and described the occurrence of burning sensation skin in a 59-year-old male patient who received Herpes zoster (Shingrix) (batch number X5T42215ZK) for prophylaxis. On 18-APR-2025, the patient received the 1st dose of Shingrix. On 18-APR-2025, less than a day after receiving Shingrix, the patient experienced burning sensation skin (Verbatim: having a b urning sensation and discomfort at the injection site.) and injection site discomfort (Verbatim: having a b urning sensation and discomfort at the injection site.). The outcome of the burning sensation skin and injection site discomfort were unknown. It was unknown if the reporter considered the burning sensation skin and injection site discomfort to be related to Shingrix. It was unknown if the company considered the burning sensation skin and injection site discomfort to be related to Shingrix. Additional Information: GSK receipt date: 27-JUN-2025 The physician called in to request data about the administration of a second dose of Shingrix after a patient reported having a burning sensation and discomfort at the injection site. More
2848351 82 F NC 07/03/2025 COVID19
 PFIZER\BIONTECH
Pruritus Pruritus
Itching/on both sides of body. Is worse in the private area/Deep itch; This is a spontaneous report ... Itching/on both sides of body. Is worse in the private area/Deep itch; This is a spontaneous report received from a Consumer or other non HCP, Program ID. An 82-year-old female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 82 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Heart stent" (unspecified if ongoing), notes: Thinks it has been 4 years since the stent. The patient's concomitant medications were not reported. Past drug history included: Morphine, reaction(s): "nauseas". Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE, Unknown manufacturer), for COVID-19 Immunization. The following information was reported: PRURITUS (non-serious) with onset 2022, outcome "not recovered", described as "Itching/on both sides of body. Is worse in the private area/Deep itch". Additional information: Patient had other conditions. Caller is patient, reporting adverse event after she took Covid shot from Pfizer. When clarifying that she experienced adverse reaction after taking Covid shot from Pfizer, she states, ever since she took it, has itching at night. Age adverse event(s) started: Does not remember exact date she took that shot. Thought she had the paper, can't find it. Had been about 3 years. Clarified, it had been about 3 years since she had the Covid shot and the itching started, right around that time, would have been 82. Weight: Probably weighs 160, Height: About 5, 5, she has shrunk. Ever since she had the itching, ever since she had the shot. Doctor said, it might be what was causing it, she did not give her anything. Itching: Clarified by caller, she only itches, at night, which is weird. Outcome of event: Clarified, caller still experiencing the itching now, it has stayed the same, it is aggravating. Treatment: No, she rubs stuff on there, that does not really help, topical stuff. When clarifying where on the body, caller experiencing the itching, she states, it starts at top of head, goes all the way, not to bottom feet but, all the way down to her ankles and below ankles, clarified, on both sides of body. Is worse in the private area. Clarified, the itching had only ever occurred at night, since she started experiencing it, about 3 year ago. Had card somewhere but, can't remember. When clarifying which arm shot was given in, caller states, she is pretty sure left arm. Thinks they gave it in car window. Was done by the county. When clarifying if this was the only Covid shot she had received, caller stated, she had 2 more. This was the third one. Did not itch when she got the other 2. Does not know if those other 2 were Pfizer or something else. Clarified, caller had 2 Covid shots prior to this third Covid shot, that was Pfizer, that she experienced the itching with. Is not taking anymore shots. Clarified, had been about 3 years now, since she took this third Covid shot. Might have been 4 years. Indication: Everybody recommended it. Concomitant Products/Medical Conditions: Nothing, other than heart stent in 2001, no she thinks it had been 4 years since the stent. Test results: No tests, no prescription medications. Vaccine Supplemental Questionnaire. Patient Details: Patient Age at Time of Vaccination: Would have been 82. Suspect Product: Facility where vaccine was administered: Unknown, given in car window, given by county, patient did not receive any other vaccines on the same date as the Pfizer vaccine. Patient was not taking any other medications (prescription medications) within 2 weeks prior to the event onset. Patient did not receive any other vaccines within 4 weeks prior to the first administration of the suspect vaccine. Stays away from doctors. No AE required a visit to the Emergency Room. No AE required a visit to a Physician's Office. Went for physical, told nurse about it, told her she thought it was Covid shot, she said, it was a great possibility, she gave her nothing. No treatment received for adverse event. Patient previously received 2 Covid shots, manufacturer unknown, unknown if Pfizer. Patient was not allergic to any previous vaccination, medications, food or other products, other than Morphine, can' t take that stuff. Clarified reaction she has to Morphine as, she gets very nauseas. Had been 50 years. Just tells them, not to give it to her. The reporter considered the event itching as caused by suspect product. During an inbound call to report an adverse event, the patient stated, "I just wanted to report, that ever since I took that booster shot, I itch at night like there's, its crazy. Patient itch from the top of my head to the bottom of my feet. And it's a deep, deep itch. It drives her nuts. So, she just wanted to report that." When asked to confirm the information being provided, patient stated, "Yes, I had a, I have an adverse reaction. I itch only at night. When I lie down. All over from the top of my head to the bottom of my feet. And it's a deep, deep itch." When asked to clarify which shots the patient had taken, patient stated, "It was the third one, from Pfizer." The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received. More
2848353 4 F 07/03/2025 MMRV
 MERCK & CO. INC.
 Y019174
Injection site erythema, Injection site induration, Injection site rash, Injecti... Injection site erythema, Injection site induration, Injection site rash, Injection site swelling, Pain More
As per the progress note upon 3-day follow-up post-injection: Was seen on 6/6/25 for 4 year well and... As per the progress note upon 3-day follow-up post-injection: Was seen on 6/6/25 for 4 year well and vaccines. MMRV given in left leg. Immediate concern that it wasn't given deep enough. Developed redness and swelling the same day. Saturday red and bumpy Yesterday - more raised and firm. Yesterday was complaining of pain. Mom with concern for cellulitis. More
2848354 11 M MI 07/03/2025 DTAPIPV
 GLAXOSMITHKLINE BIOLOGICALS
 y49bz
Extra dose administered, No adverse event, Wrong product administered Extra dose administered, No adverse event, Wrong product administered
no reaction to this extra dose of Dtap. He needed Tdap. no reaction to this extra dose of Dtap. He needed Tdap.
2848355 4 M TN 07/03/2025 MMRV
 MERCK & CO. INC.
 z006280
Erythema, Skin warm, Swelling Erythema, Skin warm, Swelling
swelled, red, and hot to touch swelled, red, and hot to touch
2848356 65 F FL 07/03/2025 MMR
TDAP
 MERCK & CO. INC.
SANOFI PASTEUR

Lymphadenopathy, Mouth ulceration, Pain, Pyrexia; Lymphadenopathy, Mouth ulcerat... Lymphadenopathy, Mouth ulceration, Pain, Pyrexia; Lymphadenopathy, Mouth ulceration, Pain, Pyrexia More
Fever, swollen lymph nodes, numerous mouth ulcers. Very painful. Lasted for 8 days Fever, swollen lymph nodes, numerous mouth ulcers. Very painful. Lasted for 8 days
2848357 17 M TX 07/03/2025 MNQ
 NOVARTIS VACCINES AND DIAGNOSTICS
 7GF79
Inappropriate schedule of product administration, No adverse event Inappropriate schedule of product administration, No adverse event
Patient was given a 3rd dose of meningitis too soon. I spoke to Dr. and informed him of this - he sa... Patient was given a 3rd dose of meningitis too soon. I spoke to Dr. and informed him of this - he said that patient will be fine. I spoke to patient's mom, and she said that patient is unharmed and is doing great. More
2848358 34 F GA 07/03/2025 HEP
 DYNAVAX TECHNOLOGIES CORPORATION
 946889
Inappropriate schedule of product administration, No adverse event Inappropriate schedule of product administration, No adverse event
The patient did not report any adverse effects, however, we needed to report that the patient receiv... The patient did not report any adverse effects, however, we needed to report that the patient received this dose 27 days after the previous dose instead of the minimum interval of 28 days. The patient is also aware. More
2848359 55 F OH 07/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 3273h
Injection site erythema, Injection site pruritus, Injection site swelling, Injec... Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth More
Patient was vaccinated in left deltoid on 7/1/25. She returned 7/3/25. roughly 48 hours later showin... Patient was vaccinated in left deltoid on 7/1/25. She returned 7/3/25. roughly 48 hours later showing a large red patch of skin around the injection site. She noticed it started about the size of a nickel and upon arrival on 7/3 it was about 1.5x2.5 inches. Reports itchy, warm patch of skin, red in color but no change in range of motion. Has been using cold compresses for the swelling. More
2848360 61 F TX 07/03/2025 PNC20
 PFIZER\WYETH
 LN4930
Diarrhoea, Erythema, Pruritus, Swelling Diarrhoea, Erythema, Pruritus, Swelling
Itchy, redness, swollen, loose stools. Patient uses cool compresses, antihistamiines. Itchy, redness, swollen, loose stools. Patient uses cool compresses, antihistamiines.
2848361 23 F TN 07/03/2025 TDAP
VARCEL
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 H4279
Z005455
Inappropriate schedule of product administration, No adverse event; Inappropriat... Inappropriate schedule of product administration, No adverse event; Inappropriate schedule of product administration, No adverse event More
No adverse event. Pt received 2nd Varicella less than 28 days from 2nd MMR. No adverse event. Pt received 2nd Varicella less than 28 days from 2nd MMR.
2848362 74 M FL 07/03/2025 COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 EH9899
E2962
FD8448
FP7135
Rheumatoid arthritis; Rheumatoid arthritis; Rheumatoid arthritis; Rheumatoid art... Rheumatoid arthritis; Rheumatoid arthritis; Rheumatoid arthritis; Rheumatoid arthritis More
Patient reports he developed rheumatoid arthritis as a result of his covid vaccines. It developed s... Patient reports he developed rheumatoid arthritis as a result of his covid vaccines. It developed sometime after his fourth shot. More
2848363 5 M NJ 07/03/2025 DTAP
 SANOFI PASTEUR
 3CA20C1
Injection site erythema, Injection site induration, Injection site irritation, I... Injection site erythema, Injection site induration, Injection site irritation, Injection site warmth, Pain More
Large red irritated area at injection site, hard and hot almost wrap around entire arm about size of... Large red irritated area at injection site, hard and hot almost wrap around entire arm about size of softball painful to move arm around More
2848364 51 F TX 07/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 58160082311
Chills, Pyrexia, Syncope Chills, Pyrexia, Syncope
Fainted during the night, fever and chills the next morning Fainted during the night, fever and chills the next morning
2848365 30 F TX 07/03/2025 VARCEL
 MERCK & CO. INC.
 Z005232
Injection site erythema, Injection site inflammation, Injection site pruritus Injection site erythema, Injection site inflammation, Injection site pruritus
Next day after vaccination, I have inflammation and visible redness in the site of the vaccination (... Next day after vaccination, I have inflammation and visible redness in the site of the vaccination (4 fingers above elbow). It is very itchy too. More
2848366 44 M NE 07/03/2025 COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH

Chest pain, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiog... Chest pain, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram normal, Left ventricular dysfunction; Left ventricular hypertrophy, Systolic dysfunction, Ventricular hypokinesia More
Within a month after having the second dose I started having some chest pain. It was incredibly seve... Within a month after having the second dose I started having some chest pain. It was incredibly severe but it was enough to take notice and be a little concerned. I did not have any pain in my arm so I dismissed a heart attack and continued on. On February 24, 2022 that morning I was having more chest pain than normal and the nurses line recommend I go to the ER. I don't believe the test they ran me through showed any issues one being an EKG. Long story short I still have the chest pains however not as severe since being put on dilTIAZem CD 180 mg/24 hour capsule and losartan 50 mg tablet. More
2848367 4 M TN 07/03/2025 DTAP
 GLAXOSMITHKLINE BIOLOGICALS
 47Y5M
Injection site erythema, Injection site pruritus, Injection site swelling Injection site erythema, Injection site pruritus, Injection site swelling
Mother reports child was having itching, swelling, and redness around injection site approx at 1400 ... Mother reports child was having itching, swelling, and redness around injection site approx at 1400 on 07/01/2025. Appt was made for 07/03/2025 for evaluation. More
2848368 53 M MD 07/03/2025 PNC20
 PFIZER\WYETH
 LJ5282
Type III immune complex mediated reaction Type III immune complex mediated reaction
Possible Arthus reaction to vaccine Possible Arthus reaction to vaccine
2848369 29 F PA 07/03/2025 MMR
 MERCK & CO. INC.
Arthralgia, Joint noise, Knee arthroplasty, Surgical failure, Tuberculosis Arthralgia, Joint noise, Knee arthroplasty, Surgical failure, Tuberculosis
It started a few months after i had bad joint pain, my knees started popping, i had a left knee repl... It started a few months after i had bad joint pain, my knees started popping, i had a left knee replacement, and the surgery went bad and i had to have a second surgery 13 years later. And now i have to live off the government, and i have to uber. The joint pain is all over my body. I went to another doctor and i found out i had tuberculosis. And i am in pain management. More
✓
2848370 4 M WA 07/03/2025 COVID19
 MODERNA
 B0011
No adverse event, Product administered to patient of inappropriate age, Wrong pr... No adverse event, Product administered to patient of inappropriate age, Wrong product administered More
Patient and his twin were meant to receive the Moderna COVID vaccine indicated for patients 6 months... Patient and his twin were meant to receive the Moderna COVID vaccine indicated for patients 6 months to 11 years of age, but were instead given the Spikevax vaccine indicated for patients 12 years and older. The order was placed incorrectly by the MA (per protocol) and then barcode scanning occurred, but because the order was placed incorrectly system did not flag the vaccine as incorrect for this patient. No unexpected side effects occurred. More
2848371 2 M CA 07/03/2025 UNK
UNK
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
 U8265AA
LK6653
Unevaluable event; Unevaluable event Unevaluable event; Unevaluable event
None stated. None stated.
2848372 58 M GA 07/03/2025 PNC20
 PFIZER\WYETH
 HM0311
Injected limb mobility decreased, Injection site pain, Injection site reaction, ... Injected limb mobility decreased, Injection site pain, Injection site reaction, Muscle swelling, Ultrasound Doppler normal More
Pt complains of significant bicep enlargement, pain, and reduced ROM after receiving PCV 20 injectio... Pt complains of significant bicep enlargement, pain, and reduced ROM after receiving PCV 20 injection last year. More
✓
2848373 4 M WA 07/03/2025 COVID19
 MODERNA
 B0011
No adverse event, Product administered to patient of inappropriate age, Wrong pr... No adverse event, Product administered to patient of inappropriate age, Wrong product administered More
Patient and his twin were meant to receive the Moderna COVID vaccine indicated for patients 6 months... Patient and his twin were meant to receive the Moderna COVID vaccine indicated for patients 6 months to 11 years of age, but were instead given the Spikevax vaccine indicated for patients 12 years and older. The order was placed incorrectly by the MA (per protocol) and then barcode scanning occurred, but because the order was placed incorrectly system did not flag the vaccine as incorrect for this patient. No unexpected side effects occurred. More
2848374 62 F WI 07/03/2025 PNC20
 PFIZER\WYETH
 LX4484
Guillain-Barre syndrome Guillain-Barre syndrome
GBS GBS
✓ ✓
2848375 81 F CA 07/03/2025 COVID19
 PFIZER\BIONTECH
 Me6072
Paraesthesia, Presyncope Paraesthesia, Presyncope
patient 1st dose Pfizer had Moderna in the past denies any reaction or side effects with Moderna pat... patient 1st dose Pfizer had Moderna in the past denies any reaction or side effects with Moderna patient felt "body tingling after vaccine", near syncope reported nurse (withheld name) LVN , patient was sitting on a chair in the hallway upon my arrival 1st blood pressure 200/79 hr. 69, initial blood pressure for this clinic appt 133/53. daughter was present. no local reaction to left deltoid More
2848376 29 F GA 07/03/2025 YF
 SANOFI PASTEUR
 UK137AA
Dizziness, Dyspnoea, Feeling jittery Dizziness, Dyspnoea, Feeling jittery
Dizziness, Lightheaded, Jittery, Shortness of Breath approximately 15 minutes following vaccine Dizziness, Lightheaded, Jittery, Shortness of Breath approximately 15 minutes following vaccine
2848378 4 GA 07/03/2025 DTAP
 GLAXOSMITHKLINE BIOLOGICALS
Injection site erythema, Rash Injection site erythema, Rash
rash and injection site redness rash and injection site redness
2848379 50 M MI 07/03/2025 PNC20
 PFIZER\WYETH
 LN4930
Insomnia, Pyrexia, Tremor Insomnia, Pyrexia, Tremor
fever, shakes, no sleep for at least 24 hours fever, shakes, no sleep for at least 24 hours
2848380 4 M NY 07/03/2025 DTAPIPV
MMRV
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 5G23D
Y017206
Injection site pain, Injection site pruritus, Injection site swelling; Injection... Injection site pain, Injection site pruritus, Injection site swelling; Injection site pain, Injection site pruritus, Injection site swelling More
left upper arm swollen about 1 day after vaccines given on left upper arm. Still active and playing ... left upper arm swollen about 1 day after vaccines given on left upper arm. Still active and playing and using arm/ hand, reports complaining of itching and tender only if the areais touched. Pt given orapred x5 days and ibuprofen. More
2848381 21 F CA 07/03/2025 MMR
TDAP
VARCEL
 MERCK & CO. INC.
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.


Anaphylactic reaction; Anaphylactic reaction; Anaphylactic reaction Anaphylactic reaction; Anaphylactic reaction; Anaphylactic reaction
Anaphylactic reaction. Seen in ER at nearest hospital after about 45 minutes to an hour. Took 50mg o... Anaphylactic reaction. Seen in ER at nearest hospital after about 45 minutes to an hour. Took 50mg of OTC Benadryl before the hospital. At the hospital, I was given Pepcid, more Benadryl, and a steroid via IV. I was discharged and prescribed Diphenhydramine HCI 25mg 2 tablets four times orally daily for 5 days, Famotidine 20 mg 1 tablet oral twice daily for 3 days, and Prednisone 20 mg 2 tablets oral daily for 5 days. More
✓
2848383 11 M NC 07/03/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 52N4S
Wrong product administered Wrong product administered
When I went to grab Menactra the vaccine for this patient, I noticed that the lot number for this va... When I went to grab Menactra the vaccine for this patient, I noticed that the lot number for this vaccine was not in correct in OP. I proceeded to writing down the lot number and notifying the NCIR lead, so it could be added. Got vaccine ready and proceeded to go to the patient's room and administer it. Right after coming out of the room, it was realized the MenB was given instead of Menactra. NCIR lead was notified and provider was notified as well. More
2848384 0.75 F MO 07/03/2025 DTAPIPVHIB
 SANOFI PASTEUR
 UK020AA
Expired product administered, No adverse event Expired product administered, No adverse event
Expired vaccine was given 3 days after expiration of vaccine. No symptoms of a reaction occured. Expired vaccine was given 3 days after expiration of vaccine. No symptoms of a reaction occured.
📋 Privacy Policy & Data Disclaimer